DSIP 5mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of DSIP supplied by Grail Formula undergoes independent third-party laboratory verification to confirm peptide identity, assay content, purity and microbiological safety. Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic, spectrometric and mass spectrometry techniques. Batch: GF-DSIP5-B241 Key analytical results include:

• Assay Content: 5.51 mg
• Identification – Retention Time: 0.991
• Identification – FTIR Spectrum: 994
• Molecular Ion Mass Identification: 848 Da
• Purity: 99.8 percent
• Bacterial Endotoxins: 0.020 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium. These analytical procedures provide confirmation of identity, purity, batch consistency and laboratory-grade research quality.

Product Overview

DSIP, short for Delta Sleep-Inducing Peptide, is a synthetic peptide research compound studied in controlled laboratory environments focused on neuropeptide signalling pathways, peptide-mediated communication systems and molecular regulatory mechanisms. The peptide has attracted scientific interest due to its unique structure and its long-standing presence within neuropeptide-related research literature. This preparation contains 5 mg of high-purity lyophilized peptide supplied in a sealed research vial. Lyophilization helps preserve peptide stability and allows researchers to reconstitute the material for controlled laboratory experimentation. Due to its defined molecular structure and established research history, DSIP remains a recognised compound within experimental peptide research models.

Peptide Overview

DSIP is a naturally occurring neuropeptide first identified during investigations into peptide-mediated signalling systems. Since its discovery, the compound has been studied extensively in laboratory settings examining peptide communication pathways and molecular regulatory processes. Within experimental models, researchers frequently investigate DSIP in relation to neuropeptide signalling networks and intracellular communication mechanisms. The compound’s relatively small molecular structure and well-characterised analytical profile have contributed to its continued relevance within peptide research. DSIP continues to be utilised in controlled laboratory studies exploring peptide-regulated biological processes and signalling dynamics.

Historical Background and Scientific Context

Scientific interest in DSIP emerged during the twentieth century as researchers sought to better understand naturally occurring peptide messengers and their role in biological signalling systems. Subsequent advances in peptide isolation, synthesis and analytical testing enabled increasingly detailed investigations into the compound’s structure and biochemical characteristics. Over the years, DSIP has remained a frequently referenced neuropeptide within scientific literature and experimental peptide research. Its continued use in laboratory investigations has contributed to a substantial body of research focused on peptide-mediated signalling mechanisms.

Mechanistic Focus in Research

Within controlled laboratory settings, DSIP is commonly studied in relation to neuropeptide signalling systems and molecular communication pathways. Research investigations frequently explore the compound in experimental models examining:

• Neuropeptide signalling pathways
• Peptide-mediated communication systems
• Intracellular signalling cascades
• Molecular regulatory mechanisms
• Peptide interaction dynamics
• Comparative neuropeptide research
• Cell signalling pathway analysis

These experimental approaches allow researchers to investigate biological processes associated with peptide-mediated communication and molecular regulation.

Research Applications

In controlled research environments, DSIP may be utilised in experimental models designed to investigate neuropeptide signalling systems and peptide-mediated molecular pathways. Examples of research applications include:

• Neuropeptide signalling research
• Peptide communication pathway studies
• Molecular signalling investigations
• Comparative peptide research
• Intracellular communication modelling
• Biochemical pathway analysis
• Controlled in vitro peptide studies

These applications are conducted exclusively within laboratory environments and are intended to improve scientific understanding of peptide-mediated biological processes.

Grail Formula Quality

Every Grail Formula research compound is produced and handled according to strict quality standards designed to support reliable laboratory experimentation. Each batch undergoes comprehensive independent analytical testing to verify:

• Peptide identity confirmation
• Assay content verification
• Purity confirmation
• Molecular mass verification
• Microbial safety screening
• Endotoxin analysis
• Heavy metal screening
• Full batch traceability

Independent laboratory verification provides researchers with transparent analytical data and confidence in the consistency of the supplied research material.

When You Choose Grail Formula

When selecting Grail Formula, researchers gain access to independently verified research compounds supported by extensive analytical documentation and batch-specific testing. Our commitment to transparency includes publication of assay results, purity verification, identity confirmation, endotoxin testing, microbial screening, elemental impurity analysis and molecular mass verification. Every batch is supported by a downloadable Certificate of Analysis, providing full traceability and independent verification from Liquilabs s.r.o. Czechia.

Research Use Limitation

• Used solely for laboratory and in vitro research
• Not approved for human consumption
• Not approved for veterinary use
• Not intended for diagnostic purposes
• Not intended for therapeutic applications
• Not permitted for clinical administration
• For research use only

• Independently analysed by Liquilabs s.r.o. Czechia
• 99.8 % purity confirmed by COA
• Assay content verified at 5.51 mg
• Molecular ion mass identified at 848 Da
• Endotoxin level measured at 0.020 EU/mg
• No detectable heavy metals or microbial contamination
• DSIP peptide research compound
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.